Project cooperationUpdated on 31 May 2026

MaternAI LiveCare™ – Continuous Lifestyle and Maternal Health Intelligence

Head of Research and Innovation at Nowocert

Dublin, Ireland

About

MaternAI LiveCare™ – Continuous Lifestyle and Maternal Health Intelligence

MaternAI LiveCare™ brings clinical-grade monitoring into everyday life using connected wearables and home sensors that capture vital trends between visits. It turns daily signals into clear, actionable insights for both lifestyle improvement and maternal care, helping clinicians detect early changes, prioritize follow-up, and support patients with personalized guidance. The platform presents a unified view of health status, risk, and adherence, while keeping the experience simple for patients and practical for care teams. It enables earlier intervention, safer pregnancies, and more effective long-term wellness through continuous, reliable visibility.

Key features include:

Connected monitoring with trusted data flow: Secure device onboarding, stable synchronization, and data validation across activity, sleep, heart rate, blood pressure, glucose, weight, and symptom inputs.
AI-assisted risk detection and routing: Early warning signals from trend shifts, personalized baselines, and multi-signal patterns, with risk levels and alerts directed to the right caregiver at the right time.
Personalized care plans and remote support: Smart reminders, coaching content, symptom check-ins, and clinician dashboards that strengthen engagement and reduce missed warning signs.

Topic

IHI Topic 1: IHI European healthcare incubator network
IHI Topic 2: An AI foundation toxicology model and framework to support waiving a second species in drug safety studies
IHI Topic 3: Decode the immuno-science of age-related mediated diseases
HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research (RIA)
HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease (RIA)
HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers (RIA)
HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care (RIA)
HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC) (IA)
HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine (RIA)
HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients (RIA)
HORIZON_MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
HORIZON_MISS-2027-02-CANCER-02 Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers
HORIZON_MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
HORIZON_MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
HORIZON_MISS-2027-02-CANCER-05 Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines
HORIZON_MISS-2027-02-CANCER-06 Support a Young Cancer Survivor Quality of Life (QoL) research programme by cancer charities and funding agencies

Type

Partner offering expertise and is looking for a consortium

Organisation

Nowocert

Company (SME)

Dublin, Ireland

Similar opportunities

Project cooperation
CortexView Imaging Intelligence™ – AI-Enhanced Acquisition and Diagnosis
- IHI Topic 1: IHI European healthcare incubator network
- Partner offering expertise and is looking for a consortium
- IHI Topic 3: Decode the immuno-science of age-related mediated diseases
- HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care (RIA)
- HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research (RIA)
- HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients (RIA)
- HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease (RIA)
- HORIZON_MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
- IHI Topic 2: An AI foundation toxicology model and framework to support waiving a second species in drug safety studies
- HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine (RIA)
- HORIZON_MISS-2027-02-CANCER-02 Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers
- HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers (RIA)
- HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC) (IA)
- HORIZON_MISS-2027-02-CANCER-06 Support a Young Cancer Survivor Quality of Life (QoL) research programme by cancer charities and funding agencies
- HORIZON_MISS-2027-02-CANCER-05 Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines
- HORIZON_MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
- HORIZON_MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
Miadreza Shafiekhah
Head of Research and Innovation at Nowocert
Dublin, Ireland
Project cooperation
PanGI Landmark Graph™ – Whole-Tract Capsule Intelligence
- IHI Topic 1: IHI European healthcare incubator network
- Partner offering expertise and is looking for a consortium
- IHI Topic 3: Decode the immuno-science of age-related mediated diseases
- HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care (RIA)
- HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research (RIA)
- HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients (RIA)
- HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease (RIA)
- HORIZON_MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
- IHI Topic 2: An AI foundation toxicology model and framework to support waiving a second species in drug safety studies
- HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine (RIA)
- HORIZON_MISS-2027-02-CANCER-02 Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers
- HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers (RIA)
- HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC) (IA)
- HORIZON_MISS-2027-02-CANCER-06 Support a Young Cancer Survivor Quality of Life (QoL) research programme by cancer charities and funding agencies
- HORIZON_MISS-2027-02-CANCER-05 Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines
- HORIZON_MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
- HORIZON_MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
Miadreza Shafiekhah
Head of Research and Innovation at Nowocert
Dublin, Ireland
Project cooperation
Digital Health & AI/ML SME | Real-World Data, Interoperability & Clinical AI Expertise Seeking CARMEN2026 Looking for a consortium to join with Widening Option
- IHI Topic 1: IHI European healthcare incubator network
- Partner offering expertise and is looking for a consortium
- IHI Topic 3: Decode the immuno-science of age-related mediated diseases
- HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care (RIA)
- HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research (RIA)
- HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients (RIA)
- HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease (RIA)
- HORIZON_MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
- IHI Topic 2: An AI foundation toxicology model and framework to support waiving a second species in drug safety studies
- HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine (RIA)
- HORIZON_MISS-2027-02-CANCER-02 Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers
- HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers (RIA)
- HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC) (IA)
- HORIZON_MISS-2027-02-CANCER-06 Support a Young Cancer Survivor Quality of Life (QoL) research programme by cancer charities and funding agencies
- HORIZON_MISS-2027-02-CANCER-05 Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines
- HORIZON_MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
- HORIZON_MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
Elifnaz Unay Kılıç
EU Technology & Funds Manager at TİGA
Ankara, Türkiye